Crinetics Pharmaceuticals, Inc. (CRNX) Stock Profile — Insider Trades & Financials

Revenue$6.2M

Net Income-$122.8M

EPS$-4.95

Market Cap$4.0B

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

R. Struthers

CEO & Executive Director

Crinetics Pharmaceuticals is a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F. Betz in 2008 and is headquartered in San Diego, California. It went public on NASDAQ in 2018.

Founded: 2008
Employees: 437
Headquarters: SAN DIEGO, CA, United States
Website: www.crinetics.com

Peer Comparison

▾

⚡

Core Efficiency

ROE?

-12.38%

ROA?

-10.90%

D/E Ratio?

0.14

Op. Margin?

-2169.55%

📊

Profitability Ratios

Net Margin?

-1993.43%

Loading company sections...

Crinetics Pharmaceuticals, Inc.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness